title: In vivo (phase I) trial and in vitro efficacy of humanized anti-Tac for the prevention of rejection in renal transplant recipients.
authors.affiliation: Division of Transplant Surgery, University of California-San Francisco 94143-0116, USA.
authors.forename: P G
authors.initials: PG
authors.lastname: Stock
authors.forename: M
authors.initials: M
authors.lastname: Lantz
authors.forename: S
authors.initials: S
authors.lastname: Light
authors.forename: F
authors.initials: F
authors.lastname: Vincenti
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D006084:Graft Rejection / Q000517:prevention & control*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D016030:Kidney Transplantation / Q000276:immunology*; D007959:Lymphocyte Culture Test, Mixed; D015375:Receptors, Interleukin-2 / Q000276:immunology
chemical_list: D000911:Antibodies, Monoclonal; D015375:Receptors, Interleukin-2